367 related articles for article (PubMed ID: 19601822)
1. Drug-like property concepts in pharmaceutical design.
Di L; Kerns EH; Carter GT
Curr Pharm Des; 2009; 15(19):2184-94. PubMed ID: 19601822
[TBL] [Abstract][Full Text] [Related]
2. Application of pharmaceutical profiling assays for optimization of drug-like properties.
Di L; Kerns EH
Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
[TBL] [Abstract][Full Text] [Related]
3. Implementation of an ADME enabling selection and visualization tool for drug discovery.
Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical profiling in drug discovery.
Kerns EH; Di L
Drug Discov Today; 2003 Apr; 8(7):316-23. PubMed ID: 12654544
[TBL] [Abstract][Full Text] [Related]
5. High-throughput in vitro profiling assays: lessons learnt from experiences at Novartis.
Faller B; Wang J; Zimmerlin A; Bell L; Hamon J; Whitebread S; Azzaoui K; Bojanic D; Urban L
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):823-33. PubMed ID: 17125403
[TBL] [Abstract][Full Text] [Related]
6. Organic chemistry in drug discovery.
MacCoss M; Baillie TA
Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
[TBL] [Abstract][Full Text] [Related]
7. A hierarchical screening methodology for physicochemical/ADME/Tox profiling.
DeWitte RS; Robins RH
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):805-17. PubMed ID: 17014396
[TBL] [Abstract][Full Text] [Related]
8. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
9. Metabolite identification and profiling in drug design: current practice and future directions.
Zhang Z; Zhu M; Tang W
Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
[TBL] [Abstract][Full Text] [Related]
10. Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability.
Nassar AE; Kamel AM; Clarimont C
Drug Discov Today; 2004 Dec; 9(23):1020-8. PubMed ID: 15574318
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessment of ADMET risks in drug discovery.
Wang J
Curr Pharm Des; 2009; 15(19):2195-219. PubMed ID: 19601823
[TBL] [Abstract][Full Text] [Related]
12. Early ADME in support of drug discovery: the role of metabolic stability studies.
Thompson TN
Curr Drug Metab; 2000 Nov; 1(3):215-41. PubMed ID: 11465046
[TBL] [Abstract][Full Text] [Related]
13. Improving early drug discovery through ADME modelling: an overview.
Wishart DS
Drugs R D; 2007; 8(6):349-62. PubMed ID: 17963426
[TBL] [Abstract][Full Text] [Related]
14. Three decades of structure- and property-based molecular design.
Müller K
Chimia (Aarau); 2014; 68(7-8):472-82. PubMed ID: 25437386
[TBL] [Abstract][Full Text] [Related]
15. Predictive approaches to increase absorption of compounds during lead optimisation.
Valko K; Butler J; Eddershaw P
Expert Opin Drug Discov; 2013 Oct; 8(10):1225-38. PubMed ID: 23865945
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options.
Aungst BJ
J Pharm Sci; 2017 Apr; 106(4):921-929. PubMed ID: 27986598
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry design principles for liver targeting through OATP transporters.
Tu M; Mathiowetz AM; Pfefferkorn JA; Cameron KO; Dow RL; Litchfield J; Di L; Feng B; Liras S
Curr Top Med Chem; 2013; 13(7):857-66. PubMed ID: 23578029
[TBL] [Abstract][Full Text] [Related]
18. Knowledge-based chemoinformatic approaches to drug discovery.
Ghose AK; Herbertz T; Salvino JM; Mallamo JP
Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
[TBL] [Abstract][Full Text] [Related]
19. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
Ekins S; Boulanger B; Swaan PW; Hupcey MA
Mol Divers; 2002; 5(4):255-75. PubMed ID: 12549676
[TBL] [Abstract][Full Text] [Related]
20. Towards a new age of virtual ADME/TOX and multidimensional drug discovery.
Ekins S; Boulanger B; Swaan PW; Hupcey MA
J Comput Aided Mol Des; 2002; 16(5-6):381-401. PubMed ID: 12489686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
